Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction

Overview of attention for article published in Journal of Onco-Nephrology, March 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#19 of 152)
Good Attention Score compared to outputs of the same age (79th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 12 X posts from 12 X users, with an upper bound of 19,884 followers.

RT @onconephsociety: Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction…

RT @onconephsociety: Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction…

RT @onconephsociety: Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction…

RT @onconephsociety: Bisphosphonate versus non-bisphosphonate treatment for hypercalcemia of malignancy in patients with renal dysfunction…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.